Evergreen Youth Secrets
  • Health News
  • Health Care
  • Staying Healthy
  • Beauty Advices
  • Health News
  • Health Care
  • Staying Healthy
  • Beauty Advices
No Result
View All Result
Evergreen Youth Secrets
No Result
View All Result
Home Health Care

Ozempic, Wegovy could reverse severe liver disease, study suggests

by
May 6, 2025
in Health Care
0
Ozempic, Wegovy could reverse severe liver disease, study suggests

Drugs made to treat diabetes and weight loss could stop or even reverse a severe liver disease, according to a new study.

The international study led by a Virginia Commonwealth University researcher found the medication semaglutide, commonly known by brand names Ozempic and Wegovy, has the ability to counter metabolic dysfunction-associated steatohepatitis, or MASH, liver disease and some of its risk factors.

MASH is characterized by inflammation and scarring caused by fat buildup in the liver. It affects roughly 20 percent of adults in the U.S. and is closely associated with risk factors like Type 2 diabetes and high blood pressure, according to the Cleveland Clinic.

Researchers administered weekly injections — either a placebo or semaglutide — to 800 patients across 37 countries between 2021 and 2023.

More than half of participants had Type 2 diabetes, and 75 percent were obese.

After nearly 17 months of injections, 62.9 percent of semaglutide patients had less inflammation and fat accumulation in their livers; 34 percent of placebo patients saw the same results.

It also reduced liver scarring in 37 percent of patients, compared to the placebo’s 23 percent.

The study’s semaglutide subjects also saw 10.5 percent weight loss, as well as improvements in liver enzymes and liver fibrosis measurements.

Lead author Dr. Arun Sanyal said the study could offer a “promising new approach for millions of patients.”

“If approved, this could offer an additional therapeutic option for patients with MASH and fibrosis,” Sanyal said. “This is crucial, given the strong link between MASH and cardiovascular, metabolic, and renal conditions, where semaglutide has already shown established health benefits.”

Sanyal’s team plans to continue the research by studying 1,200 participants from 37 countries for up to five years to look into long-term liver issues.

Previous Post

Fewer than half of Americans trust FDA, CDC to do their job

Next Post

How halt in funding hurts efforts to ensure safety of patients in medical research

Next Post
How halt in funding hurts efforts to ensure safety of patients in medical research

How halt in funding hurts efforts to ensure safety of patients in medical research

Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.

    Popular News

    A West Virginia prosecutor is warning women that a miscarriage could lead to criminal charges

    A West Virginia prosecutor is warning women that a miscarriage could lead to criminal charges

    June 6, 2025
    Kash Patel claims ‘breakthrough’ in Fauci COVID origins probe

    Kash Patel claims ‘breakthrough’ in Fauci COVID origins probe

    June 6, 2025
    Bird flu can live in raw milk for more than a week, study finds

    Bird flu can live in raw milk for more than a week, study finds

    June 6, 2025

    Trending

    FDA approves first RSV vaccine for use in at-risk adults over 50

    FDA approves first RSV vaccine for use in at-risk adults over 50

    June 8, 2024
    5 high-level officials leave CDC

    5 high-level officials leave CDC

    March 25, 2025
    Travelers and health-care providers should be on alert due to Ebola disease outbreak in Uganda, CDC warns

    Travelers and health-care providers should be on alert due to Ebola disease outbreak in Uganda, CDC warns

    February 7, 2025
    Appeals court dismisses GOP states’ attempt to intervene in mifepristone challenge

    Appeals court dismisses GOP states’ attempt to intervene in mifepristone challenge

    July 24, 2024

    Recent News

    A West Virginia prosecutor is warning women that a miscarriage could lead to criminal charges

    A West Virginia prosecutor is warning women that a miscarriage could lead to criminal charges

    June 6, 2025
    Kash Patel claims ‘breakthrough’ in Fauci COVID origins probe

    Kash Patel claims ‘breakthrough’ in Fauci COVID origins probe

    June 6, 2025

    Popular News

    • A West Virginia prosecutor is warning women that a miscarriage could lead to criminal charges
    • Kash Patel claims ‘breakthrough’ in Fauci COVID origins probe

    About Evergreen Youth Secrets

    • Contact us
    • Privacy Policy
    • Terms & Conditions
    • Email Whitelisting

    Copyright © 2025 Evergreenyouthsecrets.com. All Rights Reserved.

    No Result
    View All Result
    • Health News
    • Health Care
    • Staying Healthy
    • Beauty Advices

    Copyright © 2025 Evergreenyouthsecrets.com. All Rights Reserved.